Avantor, Inc. Finance Lease, Right-of-Use Asset, Amortization
Avantor, Inc. (AVTR) reported Finance Lease, Right-of-Use Asset, Amortization of $7.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-02-11
- Avantor, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2019-12-31 was $1.70M.
- Avantor, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2019-09-30 was $1.60M.
- Avantor, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2019-06-30 was $3.30M.
- Avantor, Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $7.50M, a 29.25% decline from fiscal 2024.
- Avantor, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $10.60M, a 8.62% decline from fiscal 2023.
- Avantor, Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $11.60M, a 8.41% increase from fiscal 2022.
- Avantor, Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $10.70M, a 3.60% decline from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $7.50M 10-K · filed 2026-02-11 | |||
| 2024-12-31 | $10.60M 10-K · filed 2026-02-11 | |||
| 2023-12-31 | $11.60M 10-K · filed 2026-02-11 | |||
| 2022-12-31 | $10.70M 10-K · filed 2025-02-07 | |||
| 2021-12-31 | $11.10M 10-K · filed 2024-02-14 | |||
| 2020-12-31 | $11.30M 10-K · filed 2023-02-14 | |||
| 2019-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $3.30M derived: sum of 2 quarters · filed 2022-02-11 | $6.60M derived: sum of 3 quarters · filed 2022-02-11 | $10.30M 10-K · filed 2022-02-11 |
| 2019-09-30 | $1.60M 10-Q · filed 2019-11-05 | $4.90M derived: sum of 2 quarters · filed 2019-11-05 | $8.60M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $3.30M 10-Q · filed 2019-08-06 | $7.00M 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |